Jaguar動物健康 JAGX 深 滬
等待開盤 09-20 09:30:00 美东时间
1.11
+0.010
+0.91%
華盛通- 最 高1.18
- 今 開1.15
- 成交量 30.01万股
- 最 低 1.05
- 昨 收 1.10
- 總市值 542.70万
- 52周最高 31.74
- 市盈率 靜 --
- 換手率 6.14%
- 52周最低 0.9501
- 委 比 86.44%
- 總股本 488.92万
- 歷史最高 100075500.00
- 量 比 0.90
- 振 幅 11.82%
- 歷史最低 1.05
- 每 手 1
- 風險率 6.80%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Jaguar Health Q2 EPS $(4.04) Misses $(1.11) Estimate, Sales $2.72M Miss $3.94M Estimate
Jaguar Health (NASDAQ:JAGX) reported quarterly losses of $(4.04) per share which missed the analyst consensus estimate of $(1.11) by 263.96 percent. This is a 861.9 percent decrease over losses of $(0.42) per share from
08-13 20:44
快讯 | jaguar health：计划在2024年10月开始商业化推出gelclair
Jaguar Health Inc: Planning to Begin Commercial Launch in Oct 2024 for Gelclair
08-13 20:19
快讯 | jaguar health：季度营业收入合计约270万美元
Jaguar Health: Qtrly Combined Net Revenue About $2.72 Mln
08-13 20:18
Earnings summary: Jaguar Health Q2 results miss estimates
More on Jaguar Health Jaguar stock plunges 60% on failed Phase 3 study for crofelemer Jaguar Health slips after update on anti-diarrheal therapy Seeking Alpha’s Quant Rating on Jaguar Health Historica...
08-13 20:13
Jaguar Health GAAP EPS of -$4.04 misses by $2.84, revenue of $2.72M misses by $0.71M
Jaguar Health press release (NASDAQ:JAGX): Q2 GAAP EPS of -$4.04 misses by $2.84. Revenue of $2.72M (+1.5% Y/Y) misses by $0.71M. Non-GAAP recurring EBITDA for the second quarter of 2024 and the secon...
08-13 20:06
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Comcast Corporation (NASDAQ:CMCSA) fell sharply during Tuesday's sess...
07-24 01:21
Why Jaguar Health Stock Is Crashing
Jaguar Health shares are falling Tuesday after the company announced its phase 3 OnTarget trial did not meet its primary endpoint. Here's a look at the details:
07-24 00:39
Jaguar Health Announces Positive Phase 3 Crofelemer Results
Jaguar Animal Health (JAGX) has provided an announcement. Jaguar Health, Inc. r...
07-23 20:28
快讯 | jaguar health - Ontarget研究的初步结果显示，这项多中心、双盲、安慰剂对照的关键临床试验未达到主要终点。
Jaguar Health - Initial Results From Ontarget Study Show That Multicenter, Doub...
07-23 20:07
